BDBM160822 US9682980, 7-(4-(3,6-Difluoro-2-methoxyphenyl)piperidin-1-yl)-3-(2,2,2-trifluoroethyl)-8-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazine
SMILES: COc1c(F)ccc(F)c1C1CCN(CC1)c1cnn2c(CC(F)(F)F)nnc2c1C(F)(F)F
InChI Key: InChIKey=OHDKBAJDMFXWTR-UHFFFAOYSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Metabotropic glutamate receptor 2 (Homo sapiens (Human)) | BDBM160822 (US9682980, 7-(4-(3,6-Difluoro-2-methoxyphenyl)pipe...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.400 | n/a | n/a | 7.0 | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description Clonally expressed human mGluR2 in HEK293 background was glutamate starved overnight in media without glutamine (GIBCO MEM 12360), containing 10% FBS... | US Patent US9682980 (2017) BindingDB Entry DOI: 10.7270/Q2J964JS | |||||||||||
More data for this Ligand-Target Pair |